Author: Ken Dropiewski

Implicity Launches a Solution to Improve Remote Monitoring of Heart Failure Patients

Company Signs Commercial Agreement with Bayer HealthCare SAS France to Accelerate Global Adoption and Improve Quality of Care for Heart Failure Patients Worldwide PARIS and CAMBRIDGE, Mass., July 22, 2021 /PRNewswire/ — Implicity, a leader in remote patient monitoring software and cardiac data management solutions, announced the company is expanding its line of products and […]

PaceMate™ and UNC School of Medicine Advance Cardiac Research with Data Partnership

BRADENTON, Fla.–(BUSINESS WIRE)–PaceMate™, the leading digital healthcare company in compliant cardiac data management, is pleased to announce a new strategic data research partnership with electrophysiologists, cardiologists, and the department research team at the University of North Carolina School of Medicine. The unmatched breadth of cardiac device data collected via PaceMate™’s […]

Late-Breaking Trial Data at TVT Demonstrate Sustained Safety and Performance of WATCHMAN FLX™ Left Atrial Appendage Closure Device

PINNACLE FLX study meets 24-month endpoint, reinforces positive 12-month outcomes with next-generation device for patients with non-valvular atrial fibrillation MARLBOROUGH, Mass., July 21, 2021 /PRNewswire/ — Today, Boston Scientific (NYSE: BSX) announced positive 24-month results from the PINNACLE FLX clinical trial assessing the safety and efficacy of the next-generation WATCHMAN FLX™ Left Atrial […]

Biospectal raises $ 4.3 million in seed funds

–  Biospectal raises $ 4.3 million in seed funds led by digital health investor SeedLink The remote monitoring and patient biosensing company will use the investment to scale its OptiBP ™ blood pressure measurement and monitoring product and operations worldwide; Renowned Interventional Cardiologist and Inventor, Dr. Fred St. Goar , MD, and Tim Juergens , of […]

Axon Therapies Announces Chad Hoskins As Chief Executive Officer

Seasoned medical device executive prepares for commercialization of innovative heart failure therapy SANTA CLARA, Calif., July 21, 2021 /PRNewswire/ — Axon Therapies, a private company focused on addressing a root cause of heart failure, today announced the appointment of seasoned medical device executive Chad Hoskins as Chief Executive Officr (CEO). Mr. Hoskins will lead […]

Cardiologs Unveils New Solution to Enable Use of Smartwatches for Remote Patient Monitoring

PARIS and BOSTON, July 21, 2021 /PRNewswire/ — Cardiologs, a global leader in artificial intelligence (AI) cardiology diagnostics, today announced the launch of Cardiologs RPM – an innovative new solution that unlocks the potential of smartwatches for remote cardiac patient monitoring. Cardiologs will debut the new offering at the Heart Rhythm Society’s annual meeting, Heart Rhythm 2021 (Booth […]

BIOMODEX Technology Enables New Milestone in Interventional Cardiology

Physicians at Montreal Heart Institute used LAACS™ solution to simulate left atrial appendage occlusion, validating the company’s efforts to reduce surgical errors and improve outcomes BOSTON, July 21, 2021 /PRNewswire/ — BIOMODEX®, the leader in bio-realistic haptic simulators for patient-specific rehearsal and physician training, today announced that its LAACS™ (Left Atrial Appendage Closure System) solution […]

LEXEO Therapeutics Expands Cardiac Gene Therapy Pipeline with Acquisition of Stelios Therapeutics and its Gene Therapy Programs for Rare Cardiovascular Diseases

LEXEO obtains exclusive rights to three investigational AAV-mediated gene therapy programs for rare cardiac disorders, all of which have no existing disease-modifying treatments available Strategic acquisition expands LEXEO’s rare cardiac gene therapy pipeline making it one of the most extensive in the field NEW YORK, July 21, 2021 (GLOBE NEWSWIRE) […]

VERQUVO® (vericiguat) Approved in the European Union

European Approval Granted to Bayer Marks Another Important Milestone for VERQUVO KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the European Commission (EC) has granted marketing authorization in the European Union (EU) for soluble guanylate cyclase (sGC) stimulator VERQUVO® (vericiguat). In […]

B-Secur Collaborates with Texas Instruments to Provide Powerful, Medical-Grade ECG/EKG Monitoring for Consumer Wearable Devices

BELFAST, Northern Ireland–(BUSINESS WIRE)–B-Secur today announced it has launched an electrocardiogram (ECG/EKG) solution based on the Texas Instruments (TI) AFE4950 analog front end (AFE) for photoplethysmography (PPG) and ECG/EKG sensing that will accelerate the design of next-generation consumer wearables. The integration provides high-performing sensing capabilities for wearable devices like premium […]